Form 4: Molina Healthcare Director Stephen H. Lockhart Reports Acquisition of Common Stock

Director Stephen H. Lockhart acquired 189 shares of Molina Healthcare common stock on January 1, 2025, as part of the company's equity incentive plan.

Summary

• Stephen H. Lockhart, a director of Molina Healthcare, Inc., reported the acquisition of 189 shares of common stock on January 1, 2025.
• The acquisition was part of the Issuer's 2019 Equity Incentive Plan and is related to Lockhart's services as a Director.
• The shares were granted at a price of $291.05, based on the closing price of Molina Healthcare's common stock on December 31, 2024.
• This grant represents one quarter, or $55,000, of the $220,000 annual equity award to each director.

Sentiment

Score: 7

Explanation: The document reflects a standard practice of equity compensation for directors, indicating a stable and well-governed company. The sentiment is neutral to positive as it aligns director interests with shareholder value.

Positives

• The equity incentive plan aligns the interests of directors with those of shareholders.
• The grant of stock to directors can be seen as a positive sign of confidence in the company's future performance.

Future Outlook

NA

Industry Context

This filing is a routine disclosure related to director compensation and is common practice for publicly traded companies. It reflects the company's commitment to aligning director interests with shareholder value through equity-based compensation.

Comparison to Industry Standards

• Equity compensation for board members is a common practice among publicly traded healthcare companies.
• Companies like UnitedHealth Group, Anthem, and Cigna also utilize equity grants as part of their director compensation packages.
• The specific value and structure of these grants can vary based on company size, performance, and industry benchmarks.

Stakeholder Impact

• Shareholders may view the equity grant positively as it aligns director interests with company performance.
• The grant has no immediate impact on employees, customers, suppliers, or creditors.

Key Dates